ALDX insider transaction filings

Aldeyra Therapeutics, Inc. — 23 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-11. Screen ALDX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-114Miller-Rich Nancy — DirectorGrant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0EDGAR
2026-06-114Clark William D — DirectorGrant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0EDGAR
2026-06-114Walker Neal — DirectorGrant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0EDGAR
2026-06-114Bronstein Ben — DirectorGrant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 5,309 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0EDGAR
2026-06-114Phillips Gary M. — DirectorGrant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 6,636 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0EDGAR
2026-06-114DEPTULA-HICKS DARLENE M — DirectorGrant/award (A): 84,557 (derivative) @ $0 · Grant/award (A): 9,756 (derivative) @ $0EDGAR
2026-06-114DOUGLAS RICHARD — DirectorGrant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 19,909 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0EDGAR
2026-06-054Brady Todd C — President and CEO, DirectorPurchase (P): 250,000 @ $1.67EDGAR
2026-03-314Brady Todd C — President and CEO, DirectorGrant/award (A): 1,880,510 (derivative) @ $0 · Grant/award (A): 632,318 (derivative) @ $0EDGAR
2026-03-204DOUGLAS RICHARD — DirectorPurchase (P): 70,000 @ $1.40EDGAR
2026-03-194Alfieri Michael — Principal Financial OfficerPurchase (P): 5,000 @ $1.42EDGAR
2025-08-154Alfieri Michael — Principal Financial OfficerPurchase (P): 2,500 @ $5.30EDGAR
2025-08-134Machatha Stephen — Chief Development OfficerSale (S): 22,073 @ $5.15EDGAR
2025-06-124Walker Neal — DirectorGrant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0EDGAR
2025-06-124Miller-Rich Nancy — DirectorGrant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0EDGAR
2025-06-124Bronstein Ben — DirectorGrant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 3,619 (derivative) @ $0 · Grant/award (A): 3,860 (derivative) @ $0EDGAR
2025-06-124JOYCE MARTIN JOSEPH — DirectorGrant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 1,689 (derivative) @ $0 · Grant/award (A): 7,238 (derivative) @ $0EDGAR
2025-06-124Phillips Gary M. — DirectorGrant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 4,825 (derivative) @ $0 · Grant/award (A): 3,619 (derivative) @ $0EDGAR
2025-06-124DOUGLAS RICHARD — DirectorGrant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 14,476 (derivative) @ $0 · Grant/award (A): 1,689 (derivative) @ $0EDGAR
2025-04-184Clark William D — DirectorGrant/award (A): 76,760 (derivative) @ $0EDGAR
2025-04-074PERCEPTIVE ADVISORS LLC — 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner
EDELMAN JOSEPH — 10% owner
Sale (S): 3,400,000 @ $1.42EDGAR
2025-03-064Brady Todd C — President and CEO, DirectorGrant/award (A): 809,710 (derivative) @ $0EDGAR
2025-03-064Machatha Stephen — Chief Development OfficerGrant/award (A): 202,427 (derivative) @ $0EDGAR

Recent 8-K events — Aldeyra Therapeutics, Inc.

FiledFormItems reportedSource
2026-07-308-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-158-K8.01 — Other EventsEDGAR
2026-06-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-04-018-K8.01 — Other EventsEDGAR
2026-03-178-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-318-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-12-168-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-138-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ALDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →